Correctly distinguishing between related neurodegenerative diseases remains challenging for clinicians, because reliable markers do not yet exist for many disorders. In the July 22 Neurology, ...

Monitoring treatment response in breast cancer is of great importance and FDG PET has demonstrated its utility in this indication. FDG PET must be performed in patients with advanced disease treated ...

At the second annual Holloway Summit, held November 30 to December 1 in Miami, frontotemporal dementia researchers showcased the current state of knowledge in finding biomarkers that identify ...

Los Angeles, June 17, 2002 An image representing the value of PET as a screening tool, and a basic science image of mouse research that demonstrates the potential to measure gene therapy using SPECT ...

Expert Rev Anticancer Ther. 2009;9(1):75-96. Based on the available data, FDG-PET alone appears to be of limited use in differentiating tumors of low malignant potential from benign tumors and ovarian ...

Positron emission tomography (PET) scans can detect cancer earlier than other imaging tests. But some types of cancer are harder to detect on a PET scan. In particular, they may miss cancers that ...